Clinical Trials Directory

Trials / Unknown

UnknownNCT06103383

Second Phase of the Pilot Study for Obtaining Mature Oocytes by in Vitro Maturation in Oocyte-donor Women

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
10 (estimated)
Sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Not accepted

Summary

In vitro maturation (IVM) is a technique for obtaining potentially fertilizable oocytes from immature oocytes. An oocyte must be mature both nuclearly and cytoplasmically in order to be competent in the reproductive process. Nuclear maturation involves an oocyte in metaphase II stage and is easily evaluated for its morphology. However, cytoplasmic maturation can only be evaluated by in vitro fertilization of that oocyte. A mature nuclear and cytoplasmic oocyte is the one capable of producing a viable embryo. This study aims to optimize the in vitro maturation (IVM) technique to achieve nuclear mature oocytes, i.e., to mature the oocytes up to the metaphase II stage. In addition, an artificial oocyte activation (AOA) will be carried out to check the cytoplasmic maturation of the oocytes, avoiding the generation of potentially viable embryos. This study corresponds to a second phase of the pilot study for the development of this technique in our IVF laboratory. We will use all we have learned in the first phase, as well as the experience acquired, to advance in the optimization of this protocol. The correct functioning of this IVM technique would mean a reduction in the costs of ovarian stimulation treatments, as lower doses and shorter stimulation times are required, which implies lower risks for women derived from the medication and less stress for them.

Conditions

Interventions

TypeNameDescription
DRUGControlled ovarian stimuation3 days stimullation protocol using hMG-HP
PROCEDUREOocyte pick upSurgical oocyte pick up without triggering
PROCEDUREOocyte in vitro maturationIn vitro maturation procedure
PROCEDUREOocyte in vitro activationIn vitro oocyte activation procedure

Timeline

Start date
2023-02-28
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2023-10-26
Last updated
2024-03-12

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06103383. Inclusion in this directory is not an endorsement.